Nigeria Pharmaceuticals & Healthcare Report Q2 2018
Nigeria's pharmaceutical and healthcare industry is a high-risk investment prospect in the Sub-Saharan African region,yet the opportunities for potential medicine sales are still vastly unexplored. The majority of multinational players will continue to optfor an indirect presence as the business climate remains decidedly difficult, yet the long-term opportunities will manifest in line witheconomic growth and greater investor sentiment. While opportunities for drugmakers will continue to be stimulated by the size andwealth of the market, the proposed healthcare budget for 2018 is indicative of the lasting effects from the oil price collapse and willensure a challenging near-term environment for healthcare providers and multinational drugmakers in Nigeria.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook